reports
Willis Lease Finance Corp: 1 director
A director at Willis Lease Finance Corp sold 6,636 shares at 53.365USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Sarepta Therapeutics Inc: 1 director
A director at Sarepta Therapeutics Inc sold 3,635 shares at 140.000USD and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Hillenbrand Inc: 4 directors
Four Directors at Hillenbrand Inc bought/maiden bought 6,237 shares at between 42.105USD and 42.690USD. The significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...
GenSight Biologics annonce le succès d'une offre d'un montant de plus ...
PARIS--(BUSINESS WIRE)-- Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, eligible PEA-PME) (la "Société"), une Société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les maladies neurodégénératives de la rétine et les troubles du système nerveux central, a annoncé aujourd'hui la reprise de la cotation des actions de la Société à la suite du succès de son Offre (tel que ce terme est défini ci-dessous), via (i) une augmentation de capital réservée à des investisseurs spécialisés et (ii) une augmentatio...
International Petroleum Corporation Announces First Quarter 2024 Finan...
International Petroleum Corporation Announces First Quarter 2024 Financial and Operational Results International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) today released its financial and operational results and related management’s discussion and analysis (MD&A) for the three months ended March 31, 2024. William Lundin, IPC's President and Chief Executive Officer, comments: “We are pleased to announce another strong quarter of production and operational performance, which was combined with favourable commodity prices. IPC achieved an average net daily pr...
BGHL (EUR): NAV(s)
BGHL (EUR): NAV(s) BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 06 May 2024. Estimated NAV Euro SharesSterling SharesEstimated NAV€ 27.7265£ 24.8404Estimated MTD return 0.25 % 0.27 %Estimated YTD return 0.65 % 1.10 %Estimated ITD return 177.27 % 148.40 % NAV and returns are calculated net of management and performance fees Market information Euro SharesAmsterdam (AEX)London (LSE)...
BGHL (GBP): NAV(s)
BGHL (GBP): NAV(s) BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 06 May 2024. Estimated NAV Euro SharesSterling SharesEstimated NAV€ 27.7265£ 24.8404Estimated MTD return 0.25 % 0.27 %Estimated YTD return 0.65 % 1.10 %Estimated ITD return 177.27 % 148.40 % NAV and returns are calculated net of management and performance fees Market information Euro SharesAmsterdam (AEX)London (LSE)...
Bouygues: First-quarter 2024 results
Bouygues: First-quarter 2024 results FIRST-QUARTER 2024 RESULTS Press release Paris, 07/05/2024 Group outlook for 2024 confirmedConstruction businesses: very solid backlog (€30.4bn) at end-March 2024, providing visibility on activityEquans: improvement in COPA and margin from activities year-on-year, rising to €133m and 2.9%, respectively, in line with the strategic Perform planBouygues Immobilier: continuing to adapt to challenging market environment1Robust financial structure: high liquidity (€13.1bn) and significant year-on-year improvement in net debt to €7.7bn The Board of Direc...
Bouygues : Résultats du premier trimestre 2024
Bouygues : Résultats du premier trimestre 2024 RÉSULTATS DU PREMIER TRIMESTRE 2024 Communiqué de presse Paris, le 07/05/2024 Confirmation des perspectives 2024 du Groupe Activités de construction : carnet de commandes (30,4 Md€) très solide à fin mars 2024, offrant de la visibilité sur l’activitéEquans : amélioration du ROCA et de la marge des activités sur un an à respectivement 133 M€ et 2,9%, en ligne avec le plan stratégique PerformBouygues Immobilier : poursuite de l’adaptation à un environnement de marché difficile1Structure financière solide : liquidité élevée (13,1 Md€) ...
Orion Corporation: Change in Orion Group Executive Management Board as...
Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025 ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD / MANAGEMENT / AUDITORS7 May 2024 at 08.30 EEST Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025 Olli Huotari, Senior Vice President responsible for Corporate Functions organization (including, i.a., Communications, Compliance, Corporate Responsibility, Intellectual Property Rights, Legal Affairs and Public Affairs) of the Orion Group and Secretary to the Board of Directors of Orion Corporation, and ...
RxSight Inc: 1 director
A director at RxSight Inc sold 40,000 shares at 60.147USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
- Oliver Metzger
- Stephan Wulf
Lonza : Lonza has improved its strategic position in biologics and is ...
>Lonza’s equity story has become more attractive since our initiation - Since we initiated the coverage of Lonza on 5 March 2024, several aspects of the equity story have further improved. The appointment of Wolfgang Wienand as CEO in April has ended a period of uncertainty regarding the company's future leadership. Even more importantly, Lonza's strategic position has improved with the acquisition of Genentech in the US. This is particularly true regarding the expect...
- Benoit Valleaux
- Roland Pfaender
- MBA
- CFA
- CCRA
SCOR : Un RN solide attendu au T1 malgré un provisionnement prudent
>Forte croissance des primes et RN publié attendu à 192 M€ - Scor publiera son RN du T1 2024 le 17 mai prochain. Nous prévoyons des primes brutes émises de 5.1 Md€, en hausse de 6.7%, avec une forte croissance en dommages (+11% à données comparables), dans le prolongement des bons renouvellements de janvier dernier, et beaucoup plus modérée en réassurance vie (+2% à d.c.). Compte tenu de la baisse des primes dommages émises l’année dernière, cela devrait se traduire ...
- Fabian Semon
Krones AG : Strong EBITDA growth trajectory & M&A track record, >40% d...
>Q1 review - Strong order intake momentum continued in Q1 and EBITDA margin improvement is progressing as planned (>10%) - In Q1, the order intake once again showed no signs of weakness (almost flat y-o-y) at a level of € 1,483m (against a tough base). The book-to-bill was maintained at >1.0x in Q1 2024 (as guided for FY 2024), which led to a continued surge in the order backlog to € 4,358m (+€ 236m q-o-q). Krones is still detached from any negative trends in the cap...
- Christophe Chaput
- Hela Zarrouk
Elis : Un bon début d’année avec une croissance organique au T1 de 6.4...
>Un CA T1 légèrement supérieur aux attentes : 1 092.4 M€ vs 1 076.4 M€ estimé - Au titre de son T1, le groupe Elis publie un chiffre d’affaires légèrement supérieur aux attentes. Celui-ci progresse de 7.8% à 1 092.4 M€ alors que nous retenions 1 076.4 M€ (écart +1.5%) et le consensus 1 079.8 M€. A périmètre et change constants, la progression ressort à 6.4% ce qui est une bonne performance (+5.8% estimé ; css +5.5%) en précisant que le groupe bénéficie au T1 d’un effe...
- Christophe Chaput
Bénéteau : CA T1 en forte baisse, comme attendu, sous l’effet des dést...
>CA T1 en baisse de 26.9% à 348.7 M€ (ODDO BHF : 384.4 M€e) - Le groupe Bénéteau publie un CA T1 en recul de 27.1% à 348.7 M€ soit un déclin plus prononcé que nous ne l’estimions (384.4 M€ estimé ; différence -9%). Par pôle d’activité, ce ralentissement des ventes au T1 s’explique par : 1/ Une forte baisse du CA Bateaux de 39% à 228.7 M€ (ODDO BHF : 281.3 M€) en raison d’un effet de base élevé (CA Bateaux T1 2023 : +57%) ainsi que du déstockage des distributeurs...
- Benoit Valleaux
- Roland Pfaender
- MBA
- CFA
- CCRA
Coface : Bon début d’année, avec un ratio combiné qui reste excellent
>Baisse des revenus comme attendu, mais avec un meilleur mix d’activités - Coface a publié hier soir son RN du T1 2024, qui a été supérieur aux attentes. Les revenus du groupe ont été de 464 M€ au T1 2024, en baisse de 2.4% en publié et de 1.6% à données comparables, en ligne avec les attentes, mais avec des primes d’assurance moindres qu’attendu et des revenus des autres activités (dont l’information) meilleures qu’anticipé. Les revenus d’assurance-crédit ont baissé ...
EQS-News: Berentzen-Gruppe Aktiengesellschaft veröffentlicht Zwischenb...
EQS-News: Berentzen-Gruppe Aktiengesellschaft / Schlagwort(e): Quartals-/Zwischenmitteilung/Quartalsergebnis Berentzen-Gruppe Aktiengesellschaft veröffentlicht Zwischenbericht Q1/2024 07.05.2024 / 07:11 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. + Pressemitteilung Nr. 8/2024 Berentzen-Gruppe Aktiengesellschaft veröffentlicht Zwischenbericht Q1/2024 ...
EQS-News: Berentzen-Gruppe Aktiengesellschaft publishes Interim Report...
EQS-News: Berentzen-Gruppe Aktiengesellschaft / Key word(s): Quarterly / Interim Statement/Quarter Results Berentzen-Gruppe Aktiengesellschaft publishes Interim Report Q1/2024 07.05.2024 / 07:11 CET/CEST The issuer is solely responsible for the content of this announcement. + Press release no. 8/2024 Berentzen-Gruppe Aktiengesellschaft publishes Interim Report Q1/2024 Earnings and profitability increased in the first quarter of the 2024 financial year Consolidated EBIT of EUR ...
Santos Limited: 1 director
A director at Santos Limited maiden bought 36,800 shares at 7.440AUD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.